Incretin-based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle: Editorial on "Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis"

基于肠促胰素的疗法在代谢功能障碍相关脂肪肝病（MASLD）治疗中的应用：拼图中的一块：关于“胰高血糖素样肽-1受体激动剂与噻唑烷二酮类药物治疗非酒精性脂肪肝病的比较：一项网络荟萃分析”的社论